Third-Line Sorafenib After Sequential Therapy With Sunitinib and mTOR Inhibitors in Metastatic Renal Cell Carcinoma - Concepedia

Concepedia

Publication | Closed Access

Third-Line Sorafenib After Sequential Therapy With Sunitinib and mTOR Inhibitors in Metastatic Renal Cell Carcinoma

60

Citations

7

References

2010

Year

Giuseppe Di Lorenzo, Carlo Buonerba, Piera Federico, Pasquale Rescigno, Michèle Milella, Cinzia Ortega, Michele Aieta, Carmine D’Aniello, Nicola Longo, Alessandra Felici,

European Urology

Third-line SorafenibUrologyOncologyMtor InhibitorsGenitourinary CancerMedicineAnti-cancer AgentCancer TreatmentPharmacologySequential Therapy

References

	Year	Citations

Page 1

Page 1